BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37497004)

  • 1. DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.
    Zhang L; Hong J; Chen W; Zhang W; Liu X; Lu J; Tang H; Yang Z; Zhou K; Xie H; Jia C; Jiang D; Zheng S
    Int J Biol Sci; 2023; 19(11):3412-3427. PubMed ID: 37497004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma.
    Wang M; Qiu ZH; Wang YZ; Lian B; Bai JK; Zhou YJ; Ji HJ
    BMC Cancer; 2023 Jan; 23(1):19. PubMed ID: 36609254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
    Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
    Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dbf4 and Cdc7 proteins promote DNA replication through interactions with distinct Mcm2-7 protein subunits.
    Ramer MD; Suman ES; Richter H; Stanger K; Spranger M; Bieberstein N; Duncker BP
    J Biol Chem; 2013 May; 288(21):14926-35. PubMed ID: 23549044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds.
    Sasi NK; Tiwari K; Soon FF; Bonte D; Wang T; Melcher K; Xu HE; Weinreich M
    PLoS One; 2014; 9(11):e113300. PubMed ID: 25412417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4.
    Sheu YJ; Stillman B
    Nature; 2010 Jan; 463(7277):113-7. PubMed ID: 20054399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDK dependent regulation of TOP2A at centromeres revealed by a chemical genetics approach.
    Wu KZ; Wang GN; Fitzgerald J; Quachthithu H; Rainey MD; Cattaneo A; Bachi A; Santocanale C
    Nucleic Acids Res; 2016 Oct; 44(18):8786-8798. PubMed ID: 27407105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation into the prereplicative complex activates the Mcm2-7 helicase for Cdc7-Dbf4 phosphorylation.
    Francis LI; Randell JC; Takara TJ; Uchima L; Bell SP
    Genes Dev; 2009 Mar; 23(5):643-54. PubMed ID: 19270162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firing of Replication Origins Frees Dbf4-Cdc7 to Target Eco1 for Destruction.
    Seoane AI; Morgan DO
    Curr Biol; 2017 Sep; 27(18):2849-2855.e2. PubMed ID: 28918948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dbf4-Cdc7 phosphorylation of Mcm2 is required for cell growth.
    Bruck I; Kaplan D
    J Biol Chem; 2009 Oct; 284(42):28823-31. PubMed ID: 19692334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways.
    Sasi NK; Bhutkar A; Lanning NJ; MacKeigan JP; Weinreich M
    Neoplasia; 2017 May; 19(5):439-450. PubMed ID: 28448802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase.
    Dick SD; Federico S; Hughes SM; Pye VE; O'Reilly N; Cherepanov P
    Structure; 2020 Aug; 28(8):954-962.e4. PubMed ID: 32521228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hierarchy of S-phase-promoting factors: yeast Dbf4-Cdc7 kinase requires prior S-phase cyclin-dependent kinase activation.
    Nougarède R; Della Seta F; Zarzov P; Schwob E
    Mol Cell Biol; 2000 Jun; 20(11):3795-806. PubMed ID: 10805723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insight into the MCM double hexamer activation by Dbf4-Cdc7 kinase.
    Cheng J; Li N; Huo Y; Dang S; Tye BK; Gao N; Zhai Y
    Nat Commun; 2022 Mar; 13(1):1396. PubMed ID: 35296675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dbf4-Cdc7 kinase promotes Mcm2-7 ring opening to allow for single-stranded DNA extrusion and helicase assembly.
    Bruck I; Kaplan DL
    J Biol Chem; 2015 Jan; 290(2):1210-21. PubMed ID: 25471369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint.
    Lee AY; Chiba T; Truong LN; Cheng AN; Do J; Cho MJ; Chen L; Wu X
    J Biol Chem; 2012 Jan; 287(4):2531-43. PubMed ID: 22123827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and roles of Cdc7 kinase under replication stress.
    Yamada M; Masai H; Bartek J
    Cell Cycle; 2014; 13(12):1859-66. PubMed ID: 24841992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.